| 28209128 | miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4. | BMC Cancer | 2017 Feb 16 | He Z | doi: 10.1186/s12885-017-3121-z. |
| 16865243 | Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer. | Oncol Rep | 2006 Sep | Oida Y | - |
| 18246798 | [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer]. | Zhonghua Zhong Liu Za Zhi | 2007 Sep | Qi RX | - |
| 20019188 | S100A4 and metastasis: a small actor playing many roles. | Am J Pathol | 2010 Feb | Boye K | doi: 10.2353/ajpath.2010.090526 |
| 20712050 | Expression of protein S100A4 is a predictor of recurrence in colorectal cancer. | World J Gastroenterol | 2010 Aug 21 | Kwak JM | - |
| 17565747 | Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer. | Int J Cancer | 2007 Oct 1 | Cabez??n T | - |
| 19194111 | Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites. | Tumour Biol | 2009 | Maelandsmo GM | doi: 10.1159/000199447 |
| 27193714 | Transcription factor Oct-1 stimulates the release of Mts1/S100A4 protein by the cancer cells. | Dokl Biochem Biophys | 2016 Mar | Portseva TN | doi: 10.1134/S1607672916020125 |
| 21837681 | Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer. | J Surg Oncol | 2012 Feb | Kang YG | doi: 10.1002/jso.22070 |
| 22200787 | Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells. | Oncol Rep | 2012 Apr | Huang L | doi: 10.3892/or.2011.1598 |
| 21924240 | Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells. | Biochem Biophys Res Commun | 2011 Sep 30 | Haase-Kohn C | doi: 10.1016/j.bbrc.2011.08.132 |
| 20332215 | Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts. | Mol Cancer Res | 2010 Apr | Radestock Y | doi: 10.1158/1541-7786.MCR-09-0307 |
| 15579771 | Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma. | J Clin Endocrinol Metab | 2004 Dec | Zou M | - |
| 19945782 | Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo. | Cancer Lett | 2010 Jun 1 | Hua J | doi: 10.1016/j.canlet.2009.11.007 |
| 12439718 | Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies. | Br J Cancer | 2002 Nov 18 | Pedersen KB | - |
| 11994292 | Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. | J Biol Chem | 2002 Jul 19 | Endo H | - |
| 24240114 | Neutrophils promote the malignant glioma phenotype through S100A4. | Clin Cancer Res | 2014 Jan 1 | Liang J | doi: 10.1158/1078-0432.CCR-13-1279 |
| 15781852 | Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. | Proc Natl Acad Sci U S A | 2005 Mar 29 | Fernandez-Fernandez MR | - |
| 15852272 | S100A4 antisense oligodeoxynucleotide suppresses invasive potential of neuroblastoma cells. | J Pediatr Surg | 2005 Apr | Gao XN | - |
| 23929008 | Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth. | Angiogenesis | 2014 Jan | Ochiya T | doi: 10.1007/s10456-013-9372-7 |
| 24378831 | Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS. | Oncol Rep | 2014 Mar | Walter I | doi: 10.3892/or.2013.2954 |
| 12445462 | Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. | Biochim Biophys Acta | 2002 Nov 4 | Belot N | - |
| 24215866 | Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties. | Cancer Lett | 2014 Mar 1 | Bettum IJ | doi: 10.1016/j.canlet.2013.10.036 |
| 24968947 | Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma. | Urol Oncol | 2014 Aug | Zhang Q | doi: 10.1016/j.urolonc.2014.02.009 |
| 26903691 | Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. | Dis Markers | 2016 | Huang S | doi: 10.1155/2016/8137378 |
| 24217649 | The E-F hand calcium-binding protein S100A4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. | Cell Physiol Biochem | 2013 | Chen X | doi: 10.1159/000354508 |
| 17504119 | Metastasis-associated protein S100A4: spotlight on its role in cell migration. | Curr Cancer Drug Targets | 2007 May | Tarabykina S | - |
| 19703228 | Methylation-associated silencing of S100A4 expression in human epidermal cancers. | Exp Dermatol | 2009 Oct | Li Y | doi: 10.1111/j.1600-0625.2009.00922.x |
| 28423501 | Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression. | Oncotarget | 2017 Mar 28 | Mudduluru G | doi: 10.18632/oncotarget.15499. |
| 29578167 | Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer. | J Cancer Res Ther | 2018 | Zhou Y | doi: 10.4103/0973-1482.172582. |
| 19808905 | Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion. | Mol Cancer Res | 2009 Oct | Kim TH | doi: 10.1158/1541-7786.MCR-09-0102 |
| 21352421 | S100A4 protects gastric cancer cells from anoikis through regulation of αv and α5 integrin. | Cancer Sci | 2011 May | Shen W | doi: 10.1111/j.1349-7006.2011.01915.x |
| 26409452 | S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2. | Tumour Biol | 2016 Mar | Xu H | doi: 10.1007/s13277-015-3709-3 |
| 23026527 | S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro. | Biomed Environ Sci | 2012 Aug | Li N | doi: 10.3967/0895-3988.2012.04.012. |
| 23900547 | S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells. | Oncol Rep | 2013 Oct | Kozono S | doi: 10.3892/or.2013.2636 |
| 27109209 | S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation. | Oncol Rep | 2016 Jun | Hua T | doi: 10.3892/or.2016.4760 |
| 23546393 | RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector. | Int J Oncol | 2013 May | Chen D | doi: 10.3892/ijo.2013.1872 |
| 17550972 | CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. | J Cell Sci | 2007 Jun 15 | Chen PS | - |
| 22287060 | Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene. | Int J Cancer | 2012 Oct 15 | Horiuchi A | doi: 10.1002/ijc.27448 |
| 23832737 | RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. | Eur Rev Med Pharmacol Sci | 2013 Jun | Yang XC | - |
| 22740693 | The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells. | J Biol Chem | 2012 Aug 31 | Liu S | doi: 10.1074/jbc.M112.343947 |
| 23316018 | Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis. | Hepatology | 2013 Jun | Yan XL | doi: 10.1002/hep.26257 |
| 26274343 | PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression. | J Clin Endocrinol Metab | 2015 Oct | Jendrzejewski J | doi: 10.1210/jc.2015-2247 |
| 22878175 | Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation. | Oncotarget | 2012 Aug | Dahlmann M | - |
| 23149742 | The metastasis-promoting S100A4 protein confers neuroprotection in brain injury. | Nat Commun | 2012 | Dmytriyeva O | doi: 10.1038/ncomms2202. |
| 19956863 | Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. | Oncol Rep | 2010 Jan | Wang HY | - |
| 24174222 | S100A4 is upregulated via the binding of c-Myb in methylation-free laryngeal cancer cells. | Oncol Rep | 2014 Jan | Liu J | doi: 10.3892/or.2013.2824 |
| 23851436 | The expression of S100A4 in human pancreatic cancer is associated with invasion. | Pancreas | 2013 Aug | Tsukamoto N | doi: 10.1097/MPA.0b013e31828804e7. |
| 23162804 | S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13. | Acta Biochim Pol | 2012 | Wang L | - |
| 20719498 | Nuclear S100A4 is a novel prognostic marker in colorectal cancer. | Eur J Cancer | 2010 Nov | Boye K | doi: 10.1016/j.ejca.2010.07.013 |
| 19653048 | S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. | J Gastrointest Surg | 2009 Oct | Ikenaga N | doi: 10.1007/s11605-009-0978-4 |
| 26741489 | Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4. | PLoS One | 2016 Jan 7 | Grottke A | doi: 10.1371/journal.pone.0146370 |
| 27193724 | The level of the Phf10 protein, a PBAF chromatin-remodeling complex subunit, correlates with the Mts1/S100A4 expression in human cancer cell lines. | Dokl Biochem Biophys | 2016 Mar | Soshnikova NV | doi: 10.1134/S1607672916020228 |
| 25252758 | LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression. | Clin Cancer Res | 2014 Nov 15 | Wang H | doi: 10.1158/1078-0432.CCR-14-0485 |
| 20093727 | Wnt up your mind - intervention strategies for S100A4-induced metastasis in colon cancer. | Gen Physiol Biophys | 2009 | Sack U | - |
| 19059703 | Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. | Cancer Lett | 2009 Jul 18 | Sherbet GV | doi: 10.1016/j.canlet.2008.10.037 |
| 26897964 | EZH2 Mediates the Regulation of S100A4 on E-cadherin Expression and the Proliferation, Migration of Gastric Cancer Cells. | Hepatogastroenterology | 2015 May | Liu S | - |
| 21195708 | The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis. | Dev Biol | 2011 Apr 15 | Andersen K | doi: 10.1016/j.ydbio.2010.12.033 |
| 19820999 | High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. | Ann Surg Oncol | 2010 Jan | Wang YY | doi: 10.1245/s10434-009-0722-z |
| 21169409 | The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. | Cancer Res | 2011 Mar 1 | Lo JF | doi: 10.1158/0008-5472.CAN-10-2350 |
| 24732359 | S100A4 is frequently overexpressed in lung cancer cells and promotes cell growth and cell motility. | Biochem Biophys Res Commun | 2014 May 9 | Chen N | doi: 10.1016/j.bbrc.2014.04.025 |
| 19506550 | S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling. | Lab Invest | 2009 Aug | Xie R | doi: 10.1038/labinvest.2009.52 |
| 24957789 | Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non-muscle-invasive bladder cancer. | Hum Pathol | 2014 Sep | Kim JH | doi: 10.1016/j.humpath.2014.04.020 |
| 21218086 | S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer. | World J Gastroenterol | 2011 Jan 7 | Huang LY | doi: 10.3748/wjg.v17.i1.69. |
| 26722531 | Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer. | Int J Clin Exp Pathol | 2015 Oct 1 | Ma G | - |
| 19513503 | Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer. | Oncol Rep | 2009 Jul | Kim JH | - |
| 25217321 | Increased expression levels of S100A4 associated with hypoxia-induced invasion and metastasis in esophageal squamous cell cancer. | Tumour Biol | 2014 Dec | Xuan X | doi: 10.1007/s13277-014-2573-x |
| 25511023 | S100A4 expression and prognosis of gastric cancer: a meta-analysis. | Genet Mol Res | 2014 Dec 12 | Wang Y | doi: 10.4238/2014.December.12.1. |
| 12532418 | Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression. | Int J Cancer | 2003 Mar 10 | Kohya N | - |
| 27770373 | Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases. | Clin Exp Metastasis | 2017 Jan | G??mez-Contreras P | doi: 10.1007/s10585-016-9827-5 |
| 16489073 | Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. | Clin Cancer Res | 2006 Feb 15 | de Silva Rudland S | - |
| 20515499 | Overexpression of S100A4 in human cancer cell lines resistant to methotrexate. | BMC Cancer | 2010 Jun 1 | Menc??a N | doi: 10.1186/1471-2407-10-250. |
| 17638890 | S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. | Cancer Res | 2007 Jul 15 | Mahon PC | - |
| 18350635 | Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer. | World J Gastroenterol | 2008 Mar 28 | Ai KX | - |
| 24952599 | RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis. | Oncotarget | 2014 May 30 | Dahlmann M | - |
| 26497012 | S100A4 interacts with mutant p53 and affects gastric cancer MKN1 cell autophagy and differentiation. | Int J Oncol | 2015 Dec | Shen W | doi: 10.3892/ijo.2015.3209 |
| 23085231 | S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. | Biochem Biophys Res Commun | 2012 Dec 14 | Sekine H | doi: 10.1016/j.bbrc.2012.10.048 |
| 28058579 | Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer. | Breast Cancer Res Treat | 2017 Feb | Egeland EV | doi: 10.1007/s10549-016-4096-1 |
| 27793047 | Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers. | Oncotarget | 2016 Nov 29 | Cheng LH | doi: 10.18632/oncotarget.12935. |
| 28675500 | FAM107B is regulated by S100A4 and mediates the effect of S100A4 on the proliferation and migration of MGC803 gastric cancer cells. | Cell Biol Int | 2017 Oct | Guo J | doi: 10.1002/cbin.10816 |
| 29342841 | miR-3189-3p Mimics Enhance the Effects of S100A4 siRNA on the Inhibition of Proliferation and Migration of Gastric Cancer Cells by Targeting CFL2. | Int J Mol Sci | 2018 Jan 13 | Bian Y | doi: 10.3390/ijms19010236. |
